GESTIPHARMA
ActiveSummary
GESTIPHARMA has been active since 1983 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €815,663 and a net result of €77,529. Equity is shrinking by ~5.3% per year across the filed fiscal years. Its solvency ranks better than 92% of 10550 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Group and network
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
MS Marketing Belgium
Shared director
→